These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1642448)

  • 1. A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's disease.
    el Yamani J; Soudan B; Mizon C; Colombel JF; Balduyck M; Cortot A; Mizon J
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():418-21. PubMed ID: 1642448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease).
    Mizon C; el Yamani J; Colombel JF; Maes P; Balduyck M; Laine A; Cortot A; Tartar A; Mizon J
    Clin Sci (Lond); 1991 May; 80(5):517-23. PubMed ID: 1851694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Crohn's disease activity and alpha 1-antitrypsin in faeces.
    Arndt B; Schürmann G; Betzler M; Herfarth C; Schmidt-Gayk H
    Lancet; 1992 Oct; 340(8826):1037. PubMed ID: 1357424
    [No Abstract]   [Full Text] [Related]  

  • 6. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces.
    van Oostayen JA; Wasser MN; van Hogezand RA; Griffioen G; Biemond I; Lamers CB; de Roos A
    AJR Am J Roentgenol; 1997 Feb; 168(2):429-33. PubMed ID: 9016220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease.
    Mizon C; Becuwe C; Balduyck M; Colombel JF; Cortot A; Mizon J; Degand P
    Clin Chem; 1988 Nov; 34(11):2268-70. PubMed ID: 3263222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular form of faecal alpha 1 antitrypsin in patients with Crohn's disease.
    Mizon C; eL Yamani J; Mizon J; Colombel JF; Cortot A
    Gut; 1992 Apr; 33(4):572. PubMed ID: 1582608
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
    Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
    J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal alpha 1-antitrypsin as a measure of Crohn's disease activity. The effect of therapy and anatomical extent of disease.
    Meyers S; Lichtiger S; Feuer EJ; Lahman EA; Janowitz HD
    J Clin Gastroenterol; 1988 Oct; 10(5):491-7. PubMed ID: 3263408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
    Delefortrie Q; Schatt P; Grimmelprez A; Gohy P; Deltour D; Collard G; Vankerkhoven P
    Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Dig Dis Sci; 1994 Mar; 39(3):507-12. PubMed ID: 8131686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.
    Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A
    Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of developmental criteria in Crohn's disease].
    Deflandre J
    Rev Med Liege; 1984 Dec; 39(23):846-53. PubMed ID: 6335279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.